FDA Approves Remdesivir, Becomes First COVID-19 Treatment

On Thursday, the U.S. Food and Drug Administration (FDA) approved the antiviral drug Remdesivir for use in adult and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization. The drug becomes the first FDA-approved treatment for COVID-19 and should only be administered in a hospital or healthcare setting.

A full FDA news release on the Remdesivir approval is available here.